Document is current

Article History

Accepted: 1 November 2020

First Online: 21 November 2020

Declarations

:

: No sources of funding were used in the preparation of this editorial.

: The Drug Safety Research Unit (DSRU) is an independent charity (No. 327206), which works in association with the University of Portsmouth. It receives unconditional donations from pharmaceutical companies. The companies have no control on the conduct or the publication of the studies conducted by the DSRU. The DSRU are leading a consortium whose aim is to conduct a post-authorization safety and effectiveness study for a vaccine(s) for COVID-19 in the UK. The DSRU is not involved with monitoring the clinical trials for COVID-19 vaccines. Saad Shakir has worked in pharmacovigilance for many years and during that time has evaluated thousands of case reports and acted as a chairman and member of Data Safety Monitoring Boards for medicines. Miranda Davies, Samantha Lane, and Saad Shakir have no conflicts of interest that are directly relevant to the content of this editorial.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: SS was responsible for the content and contributed knowledge and expertise in this area. MD and SL assisted with the development and reviews of the manuscript. All authors read and approved the final version.